Eren Demirhan
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Cancer Research top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Co-authors
- Fred SaadDe PhungMaha HussainKarim FizaziAndrew KrivoshikPer RathenborgNeal D. ShoreKatharina Modelska
- Topics
- Chronic Lymphocytic Leukemia Research (8 papers)Chronic Myeloid Leukemia Treatments (7 papers)Prostate Cancer Treatment and Research (5 papers)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Eren Demirhan
14 papers receiving 947 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 678
- Oncology 290
- Cancer Research 231
- Radiology, Nuclear Medicine and Imaging 219
- Molecular Biology 201
Countries citing papers authored by Eren Demirhan
This map shows the geographic impact of Eren Demirhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eren Demirhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eren Demirhan more than expected).
Fields of papers citing papers by Eren Demirhan
This network shows the impact of papers produced by Eren Demirhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eren Demirhan. The network helps show where Eren Demirhan may publish in the future.
Co-authorship network of co-authors of Eren Demirhan
This figure shows the co-authorship network connecting the top 25 collaborators of Eren Demirhan. A scholar is included among the top collaborators of Eren Demirhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eren Demirhan. Eren Demirhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 21 | |
| 3 | 38 | |
| 4 | 3 | |
| 5 | Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancerbreakdown → | 677 |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 26 | |
| 9 | 82 | |
| 10 | 17 | |
| 11 | 67 | |
| 12 | 1 | |
| 13 | Comparison of steady-state imatinib (IM) trough levels, clinical response, and safety between Caucasian and Asian patients with chronic myeloid leukemia in chronic phase (CML-CP) treated with 400mg and 800mg daily doses of IM in the tyrosine kinase inhibi | 3 |
| 14 | 4 | |
| 15 | 3 |
About Eren Demirhan
Eren Demirhan is a scholar working on Genetics, Hematology and Oncology, having authored 15 papers that have together received 955 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (678 citations), Cancer Research (231 citations) and Hematology (151 citations). Eren Demirhan has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Fred Saad, De Phung, Maha Hussain, Karim Fizazi, Andrew Krivoshik, Per Rathenborg, Neal D. Shore, Katharina Modelska, Cora N. Sternberg and Ubirajara Ferreira. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.